Literature DB >> 3139568

A pneumococcal surface protein (PspB) that exhibits the same protease sensitivity as streptococcal R antigen.

L S McDaniel1, D E Briles.   

Abstract

A monoclonal antibody against Streptococcus pneumoniae, designated T4A49, detected a 64,000-molecular-weight protein that was immunologically unrelated to the previously described surface protein PspA. This new protein, designated PspB, was pepsin sensitive and trypsin resistant, as is the R antigen of type 28 group A streptococci.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3139568      PMCID： PMC259685          DOI： 10.1128/iai.56.11.3001-3003.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  11 in total

1.  Characterization of the antibody to the C-carbohydrate produced by a transplantable mouse plasmacytoma.

Authors:  M Cohn; G Notani; S A Rice
Journal:  Immunochemistry       Date:  1969-01

2.  Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies.

Authors:  L S McDaniel; G Scott; K Widenhofer; J M Carroll; D E Briles
Journal:  Microb Pathog       Date:  1986-12       Impact factor: 3.738

3.  Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate.

Authors:  D E Brundish; J Baddiley
Journal:  Biochem J       Date:  1968-12       Impact factor: 3.857

4.  Mouse-protective effect of rabbit anti-R-protein antibodies against group B streptococci type II carrying R-protein. Lack of effect on type III carrying R-protein.

Authors:  V Lindén
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1983-04

5.  The occurrence of R-protein among isolates of group B streptococci from human sources.

Authors:  V Lindén; K K Christensen; P Christensen
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1983-04

6.  Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.

Authors:  L S McDaniel; W H Benjamin; C Forman; D E Briles
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

7.  Preparation and properties of a protein (R antigen) occurring in streptococci of group A, type 28 and in certain streptococci of other serological groups.

Authors:  R C LANCEFIELD; G E PERLMANN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

8.  Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).

Authors:  L S McDaniel; J Yother; M Vijayakumar; L McGarry; W R Guild; D E Briles
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

9.  Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.

Authors:  L S McDaniel; G Scott; J F Kearney; D E Briles
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene.

Authors:  J R Scott; P C Guenthner; L M Malone; V A Fischetti
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307
View more
  5 in total

1.  Western blot analysis of immunoglobulin G antibodies to pneumococcal protein antigens in healthy adults.

Authors:  J Renneberg; M Svinhufvud; K Prellner; P Christensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.

Authors:  D E Briles; C Forman; J C Horowitz; J E Volanakis; W H Benjamin; L S McDaniel; J Eldridge; J Brooks
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

4.  PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.

Authors:  L S McDaniel; J S Sheffield; P Delucchi; D E Briles
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

Review 5.  Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).

Authors:  D E Briles; R C Tart; E Swiatlo; J P Dillard; P Smith; K A Benton; B A Ralph; A Brooks-Walter; M J Crain; S K Hollingshead; L S McDaniel
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.